Actively Recruiting

Phase 2
Phase 3
Age: 18Years - 75Years
All Genders
NCT05504265

Perioperative Analgesia Modes in Minimally Invasive Esophagectomy

Led by Cancer Institute and Hospital, Chinese Academy of Medical Sciences · Updated on 2025-03-20

102

Participants Needed

1

Research Sites

166 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

This study was designed to compare analgesic efficacy and safety of different perioperative analgesic modes in minimally invasive esophagectomy for esophageal cancer.

CONDITIONS

Official Title

Perioperative Analgesia Modes in Minimally Invasive Esophagectomy

Who Can Participate

Age: 18Years - 75Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Aged 18 to 75 years
  • Undergoing laparoscopic, thoracoscopic, or robotic-assisted minimally invasive esophagectomy
  • Provided informed consent to participate
Not Eligible

You will not qualify if you...

  • History of cholecystitis or urolithiasis within the past 3 months
  • History of atherothrombosis, stroke, or myocardial infarction
  • Presence of lung diseases such as pneumonia, atelectasis, emphysema, or pulmonary bullae
  • Preoperative cardiac function grade III or higher or coronary artery stenosis
  • Preoperative use of a thoracic drainage tube
  • Long-term heavy alcohol use (more than 4 drinks/day or 14 drinks/week for men; more than 3 drinks/day or 7 drinks/week for women)
  • Opioid tolerance from taking high doses of opioids daily for a week or more
  • Painful skin complications like rashes or blisters
  • Conversion to open surgery from minimally invasive approach
  • Limited postoperative ventilation or endotracheal intubation lasting more than 24 hours

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Cancer Hospital Chinese Academy of Medical Sciences

Beijing, China

Actively Recruiting

Loading map...

Research Team

Z

zhu zhixiang

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

3

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here